NCT00389532View on ClinicalTrials.gov

Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

September 30, 2008

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)

Influenza vaccine

BIOLOGICAL

Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)

Influenza vaccine

Trial Locations (1)

23507

Norfolk

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00389532 - Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine | Biotech Hunter | Biotech Hunter